Tectonic Therapeutic | AVRO - Выручка от реализации





Продажи Изменить Дата
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Celltrion KRW 1.24T 90B 2026-06
Cspc Pharmaceutical CNY 6.47B 355.1M 2026-03
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 28.31B 2.27B 2026-03
Gilead Sciences USD 7B 930M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
Kangmei Pharma CNY 1.08B 288.27M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
MacroGenics USD 20.8M 20.43M 2026-03
Medical Developments International AUD 21.57M 12.04M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organigram Holdings CAD 59.79M 3.74M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Pharma Mar EUR 42.9M 47.3M 2026-03
Qiagen NV USD 419.22M 38.16M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 11.24B 60M 2026-03
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Sartorius EUR 899.1M 28.5M 2026-03
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Takeda JPY 1.09T 100B 2026-03
Tilray USD 217.51M 74.75M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M 2026-03